CN Patent

CN115745913B — 曲法罗汀多晶型及其制备方法

Assigned to Nanjing Minoway Medical Technology Co ltd · Expires 2024-05-24 · 2y expired

What this patent protects

本发明提供了一种曲法罗汀化合物的多晶型形式及其制备方法和应用，其中晶型II具有优良的稳定性，且适合放大生产，适于药物研发和工业化应用。

USPTO Abstract

本发明提供了一种曲法罗汀化合物的多晶型形式及其制备方法和应用，其中晶型II具有优良的稳定性，且适合放大生产，适于药物研发和工业化应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN115745913B
Jurisdiction
CN
Classification
—
Expires
2024-05-24
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Minoway Medical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.